Clinical Trial

A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

Study acronym: PEAK
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The objective of this study is to compare the efficacy and safety of MACI® vs arthroscopic microfracture in the treatment of participants aged 10 to 17 years with symptomatic articular chondral or osteochondral defects of the knee.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2018-07-15; most recent amendment 2026-06-19.
Trial Details
NCT Number NCT03588975
Lead Sponsor Vericel Corporation
Conditions Chondral Defect, Osteochondritis Dissecans (OCD), Articular Cartilage Defect, Articular Cartilage Disorder of Knee
Enrollment 45 participants
Start Date 2018-10-24
Primary Completion 2030-02 (estimated)
Study Completion 2030-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-24